Today we present 27 new placebo and nocebo research papers, book chapters, comments and abstracts identified during August 2022. As usual, they are based on new PUBMED publication using the search terms „placebo“ and „nocebo“ and are hand-selected from more than 697 new publications during the preceding month. Previously published monthly updates can be found in our archive. Todays selection as well as all previously identified papers will also go into our placebo research library that currently contains nearly 5,000 relevant papers. If you would like to get access to the full database, please register for our newsletter and provide us with your email address and affiliation.
Blease, C. (2022).
Sharing online clinical notes with patients: implications for nocebo effects and health equity. J Med Ethics. doi:10.1136/jme-2022-108413
https://www.ncbi.nlm.nih.gov/pubmed/35918134
Bloomfield-Clagett, B., Ballard, E. D., Greenstein, D. K., Wilkinson, S. T., Grunebaum, M. F., Murrough, J. W., Mathew, S. J., Phillips, J. L., Fava, M., Sanacora, G. & Zarate, C. A. (2022).
A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Non-Suicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine. Int J Neuropsychopharmacol. doi:10.1093/ijnp/pyac055
https://www.ncbi.nlm.nih.gov/pubmed/35994774
Brietzke, C., Cesario, J. C. S., Hettinga, F. J., & Pires, F. O. (2022).
The reward for placebos: mechanisms underpinning placebo-induced effects on motor performance. Eur J Appl Physiol. doi:10.1007/s00421-022-05029-8
https://www.ncbi.nlm.nih.gov/pubmed/36006479
De Silva, T. A., Alphonsus, L., Ma, C., Hogan, M., Sedano, R., Narula, N., Danese, S., Peyrin-Biroulet, L., MacDonald, J. K., Singh, S. & Jairath, V. (2022).
Placebo rates in randomized controlled trials of proctitis therapy: A systematic review and meta-analysis. J Crohns Colitis. doi:10.1093/ecco-jcc/jjac109
https://www.ncbi.nlm.nih.gov/pubmed/35930405
Dutt, K., Srinivasan, A., & Van Langenberg, D. (2022).
The Nocebo Effect in a Non-Medical Switching Program from Originator to Biosimilar Infliximab in Inflammatory Bowel Disease. BioDrugs. doi:10.1007/s40259-022-00548-4
https://www.ncbi.nlm.nih.gov/pubmed/35960446
Giandomenico, D., Nuria, R., Alessandro, A., Matteo, G., Mattia, I., Marco, T., & Francesco, C. (2022).
Differences between experimental and placebo arms in manual therapy trials: a methodological review. BMC Med Res Methodol, 22(1), 219. doi:10.1186/s12874-022-01704-8
https://www.ncbi.nlm.nih.gov/pubmed/35941533
Guscoth, L. B., & Cyna, A. M. (2022).
Nocebo language in anaesthetic patient written information. Anaesthesia. doi:10.1111/anae.15824
https://www.ncbi.nlm.nih.gov/pubmed/35918796
Howe, L. C., Goyer, J. P., & Crum, A. J. (2022).
“Harnessing the placebo effect: Exploring the influence of physician characteristics on placebo response”: Correction. Health Psychol. doi:10.1037/hea0001235
https://www.ncbi.nlm.nih.gov/pubmed/35925707
Hruschak, V., Flowers, K. M., Patton, M., Merchantz, V., Schwartz, E., Edwards, R., Kaptchuk, T., Kang, J., Dossett, M. & Schreiber, K. (2022).
Experiences of Patients Taking Conditioned Open-Label Placebos for Reduction of Postoperative Pain and Opioid Exposure After Spine Surgery. Int J Behav Med. doi:10.1007/s12529-022-10114-5
https://www.ncbi.nlm.nih.gov/pubmed/35915346
Kang, H., Miksche, M. S., & Ellingsen, D. M. (2022).
The association between personality traits and placebo effects: a preregistered systematic review and meta-analysis. Pain. doi:10.1097/j.pain.0000000000002753
https://www.ncbi.nlm.nih.gov/pubmed/35947877
Khouri, C., Larabi, A., Verger, P., Gauna, F., Cracowski, J. L., & Ward, J. (2022).
Impact of Vaccine Hesitancy on Onset, Severity and Type of Self-reported Adverse Events: A French Cross-Sectional Survey. Drug Saf. doi:10.1007/s40264-022-01220-0
https://www.ncbi.nlm.nih.gov/pubmed/35972651
Kleine-Borgmann, J., Dietz, T. N., Schmidt, K., & Bingel, U. (2022).
No long-term effects after a three-week open-label placebo treatment for chronic low back pain: a three-year follow-up of a randomized controlled trial. Pain. doi:10.1097/j.pain.0000000000002752
https://www.ncbi.nlm.nih.gov/pubmed/35947884
Kube, T., Kirsch, I., Glombiewski, J. A., Witthoft, M., & Brascher, A. K. (2022).
Remotely provided open-label placebo reduces frequency of and impairment by allergic symptoms. Psychosom Med. doi:10.1097/PSY.0000000000001110
https://www.ncbi.nlm.nih.gov/pubmed/35980787
Meissner, K. (2022).
Placebo, nocebo: Believing in the field of medicine. Front Pain Res, 3, 972169. doi:10.3389/fpain.2022.972169
https://www.ncbi.nlm.nih.gov/pubmed/35965595
Pardo-Cabello, A. J., Manzano-Gamero, V., & Puche-Canas, E. (2022).
Placebo: a brief updated review. Naunyn Schmiedebergs Arch Pharmacol. doi:10.1007/s00210-022-02280-w
https://www.ncbi.nlm.nih.gov/pubmed/35943515
Penson, P. E., Bruckert, E., Marais, D., Reiner, Z., Pirro, M., Sahebkar, A., Bajraktari, G., Mirrakhimov, E., Rizzo, M., Mikhailidis, D. P., Sachinidis, A., Gaita, D., Latkovskis, G., Mazidi, M., Toth, P. P., Pella, D., Alnouri, F., Postadzhiyan, A., Yeh, H. I., Mancini, G. B. J., von Haehling, S., Banach, M. & International Lipid Expert Panel (ILEP) (2022).
Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP). J Cachexia Sarcopenia Muscle, 13(3), 1596-1622. doi:10.1002/jcsm.12960
https://www.ncbi.nlm.nih.gov/pubmed/35969116
Perivolaris, A., Ainsworth, N. J., Alexopoulos, G. S., Bingham, K. S., Flint, A. J., Marino, P., Neufeld, N. H., Rothschild, A. J., Voineskos, A. N., Whyte, E. M., Mulsant, B. H. & STOP-PD II Study Group (2022).
Placebo Effect in Randomized Trials of Major Depressive Disorder With Psychotic Features: A Systematic Review and Descriptive Meta-Analysis. J Clin Psychopharmacol. doi:10.1097/JCP.0000000000001589
https://www.ncbi.nlm.nih.gov/pubmed/35977030
Prinz, J., Maffulli, N., Fuest, M., Walter, P., Hildebrand, F., & Migliorini, F. (2022).
Placebo administration for dry eye disease: a level I evidence based systematic review and meta-analysis. Int J Clin Pharm. doi:10.1007/s11096-022-01439-y
https://www.ncbi.nlm.nih.gov/pubmed/35939178
Qi, L. Y., Yan, S. Y., Yang, J. W., & Liu, C. Z. (2022).
The impact of expectancy on the efficacy of acupuncture treatment for postprandial distress syndrome: Secondary analysis of a randomized clinical trial. Neurogastroenterol Motil, e14447. doi:10.1111/nmo.14447
https://www.ncbi.nlm.nih.gov/pubmed/35946062
Rohloff, G., Souza, D. B., Ruiz-Moreno, C., Del Coso, J., & Polito, M. D. (2022).
Stimulus Expectancy and Stimulus Response of Caffeine on 4-km Running Performance: A Randomized, Double-blind, Placebo-controlled and Crossover Study. Int J Exerc Sci, 15(2), 645-654.
https://www.ncbi.nlm.nih.gov/pubmed/35992183
Roydhouse, J., Tomko, R. L., Gray, K. M., & Gutman, R. (2022).
Assessment of patient perception of treatment assignment and patient-reported outcomes in a cannabis use disorder trial. Am J Drug Alcohol Abuse, 1-11. doi:10.1080/00952990.2022.2097918
https://www.ncbi.nlm.nih.gov/pubmed/35904459
Schmidt, S. (2022).
Context matters! What is really tested in an RCT? BMJ Evid Based Med. doi:10.1136/bmjebm-2022-111966
https://www.ncbi.nlm.nih.gov/pubmed/36008125
Schmitz, J., Schmidt, K., Ludtke, K., Kropp, P., & Dresler, T. (2022).
[Publisher Erratum: Placebo in der Schmerztherapie]. MMW Fortschr Med, 164(14), 74. Article in German. doi:10.1007/s15006-022-1161-z
https://www.ncbi.nlm.nih.gov/pubmed/35941468
Stone, M. B., Yaseen, Z. S., Miller, B. J., Richardville, K., Kalaria, S. N., & Kirsch, I. (2022).
Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis. BMJ, 378, e067606. doi:10.1136/bmj-2021-067606
https://www.ncbi.nlm.nih.gov/pubmed/35918097
Vera, J., Redondo, B., Ocaso, E., Martinez-Guillorme, S., Molina, R., & Jimenez, R. (2022).
Manipulating expectancies in optometry practice: Ocular accommodation and stereoacuity are sensitive to placebo and nocebo effects. Ophthalmic Physiol Opt. doi:10.1111/opo.13036
https://www.ncbi.nlm.nih.gov/pubmed/35959593
Weng, L., van Laarhoven, A. I. M., Peerdeman, K. J., & Evers, A. W. M. (2022).
Do individual psychological characteristics predict induction and generalization of nocebo and placebo effects on pain and itch? Front Psychiatry, 13, 838578. doi:10.3389/fpsyt.2022.838578
https://www.ncbi.nlm.nih.gov/pubmed/35990075
Zhou, R., Zhu, Y. J., Chen, X., Ma, H. C., Liu, Y. H., Chang, X. S., Chen, Y. D., Yu, Y. Y., Xiao, Z. Z., Liu, L. R., Li, Y. & Zhang, H. B. (2022).
Effect of Sham Acupuncture on Chronic Pain: A Bayesian Network Meta-analysis. Pain Med. doi:10.1093/pm/pnac126
https://www.ncbi.nlm.nih.gov/pubmed/35993612
Download PDF here.